Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesDividends payablesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Notes Payables (2018 - 2023)

cbdMD's Notes Payables history spans 6 years, with the latest figure at $2492.0 for Q3 2023.

  • For Q3 2023, Notes Payables fell 74.07% year-over-year to $2492.0; the TTM value through Sep 2023 reached $2492.0, down 74.07%, while the annual FY2023 figure was $2492.0, 74.07% down from the prior year.
  • Notes Payables for Q3 2023 was $2492.0 at cbdMD, down from $4135.0 in the prior quarter.
  • Across five years, Notes Payables topped out at $163858.0 in Q1 2020 and bottomed at $2492.0 in Q3 2023.
  • The 5-year median for Notes Payables is $56106.0 (2020), against an average of $46295.9.
  • The largest annual shift saw Notes Payables surged 82.06% in 2020 before it plummeted 88.0% in 2023.
  • A 5-year view of Notes Payables shows it stood at $34404.0 in 2019, then surged by 64.44% to $56573.0 in 2020, then increased by 6.88% to $60468.0 in 2021, then plummeted by 83.86% to $9758.0 in 2022, then tumbled by 74.46% to $2492.0 in 2023.
  • Per Business Quant, the three most recent readings for YCBD's Notes Payables are $2492.0 (Q3 2023), $4135.0 (Q2 2023), and $7375.0 (Q1 2023).